FindTrial
Sign In

ASSESSMENT OF FACTORS ASSOCIATED WITH FAILURE OF DRUGS USED IN TREATMENT OF HIV

ASSESSMENT OF FACTORS ASSOCIATED WITH FAILURE OF THIRD LINE ANTIRETROVIRAL TREATMENT(ART) IN PEOPLE LIVING WITH HUMAN IMMUNO DEFICIENCY VIRUS(PLHIV)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/07/034840
Enrollment
25
Registered
2021-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B20- Human immunodeficiency virus [HIV]disease

Interventions

None listed

Sponsors

Maulana Azad Medical College and associated Lok Nayak Hospitals
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)PLHIV with failure of 3rd Line ART defined as HIV -1 Plasma Viral load > 1000 copies/ml after 6 months of third line ART(Dolutegravir+ Darunavir/ritonavir) as per NACO guidelines) 2)Subjects willing to provide informed consent.

Exclusion criteria

Exclusion criteria: NONE

Design outcomes

Primary

MeasureTime frame
Proportion of PLHIV failing third line ART with clinical failure and opportunistic infections.Timepoint: Presentation to ART clinic to assessment by a performa(approx 1 year)—

Secondary

MeasureTime frame
Occurence of non adherence to ART among this population. Timepoint: Presentation to ART clinic to assessment by a performa(approx 1 year)—

Countries

India

Contacts

Public ContactDr M RAM KUMAR

MAULANA AZAD MEDICAL COLLEGE AND ASSOCIATED LOK NAYAK HOSPITAL

drsanuradha@gmail.com9811184924

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026